In contrast, mutations associated with the AD form are expressed normally but enhance EGF‐dependent ERK1/2 phosphorylation.28 Functional studies such as these are especially important for the missense alterations described here where pathogenicity has not been conclusively established (Table S7, Supplementary note 4). The gene discussed is MAPK3; the disease is Alzheimer disease.